Published in J Pediatr Hematol Oncol on May 01, 2009
RAS diseases in children. Haematologica (2014) 0.95
Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet (2003) 5.16
Germline KRAS mutations cause Noonan syndrome. Nat Genet (2006) 4.48
Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms. Blood (2014) 2.72
Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes. Blood (2012) 2.69
Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. Haematologica (2008) 2.69
Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. Blood (2004) 2.62
Mutations in CBL occur frequently in juvenile myelomonocytic leukemia. Blood (2009) 2.15
Natural history and early diagnosis of LAD-1/variant syndrome. Blood (2006) 1.85
Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98. J Clin Oncol (2006) 1.82
The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease. Blood (2005) 1.80
RNA and protein evidence for haplo-insufficiency in Diamond-Blackfan anaemia patients with RPS19 mutations. Br J Haematol (2004) 1.76
Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL. Blood (2013) 1.74
Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival. Blood (2005) 1.61
Editorial policies of pediatric journals: survey of instructions for authors. Arch Pediatr Adolesc Med (2010) 1.44
Biochemical and functional characterization of germ line KRAS mutations. Mol Cell Biol (2007) 1.41
Successful treatment of refractory chronic disseminated candidiasis after prolonged administration of caspofungin in a child with acute myeloid leukemia. Pediatr Blood Cancer (2007) 1.40
Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia. Nature (2003) 1.39
Childhood and adolescent lymphoid and myeloid leukemia. Hematology Am Soc Hematol Educ Program (2004) 1.35
Juvenile-like (inflammatory/hyperplastic) mucosal polyps of the gastrointestinal tract in neurofibromatosis type 1. Histopathology (2014) 1.31
Gene expression-based classification as an independent predictor of clinical outcome in juvenile myelomonocytic leukemia. J Clin Oncol (2010) 1.25
Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study. Blood (2007) 1.23
Classification of childhood aplastic anemia and myelodysplastic syndrome. Hematology Am Soc Hematol Educ Program (2011) 1.16
Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome. Blood (2011) 1.12
An unexpected new role of mutant Ras: perturbation of human embryonic development. J Mol Med (Berl) (2007) 1.11
Targeting RAS signaling pathways in juvenile myelomonocytic leukemia. Curr Drug Targets (2007) 1.09
SHP-2 and myeloid malignancies. Curr Opin Hematol (2004) 1.08
Genotype-phenotype correlation in cases of juvenile myelomonocytic leukemia with clonal RAS mutations. Blood (2008) 1.07
Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome. Blood (2010) 1.05
Angiogenesis as a target in neuroblastoma. Eur J Cancer (2008) 1.04
Spliceosomal gene aberrations are rare, coexist with oncogenic mutations, and are unlikely to exert a driver effect in childhood MDS and JMML. Blood (2012) 1.04
Non-hematopoietic stem cell transplantation treatment of juvenile myelomonocytic leukemia: a retrospective analysis and definition of response criteria. Pediatr Blood Cancer (2007) 1.03
TERC mutations in children with refractory cytopenia. Haematologica (2006) 1.02
Germline mutations in components of the Ras signaling pathway in Noonan syndrome and related disorders. Cell Cycle (2006) 1.01
Intriguing response to azacitidine in a patient with juvenile myelomonocytic leukemia and monosomy 7. Blood (2009) 1.00
Myelodysplastic syndrome in children and adolescents. Semin Hematol (2008) 0.99
Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes. Ann Hematol (2008) 0.99
Interferon-gamma sensitizes resistant Ewing's sarcoma cells to tumor necrosis factor apoptosis-inducing ligand-induced apoptosis by up-regulation of caspase-8 without altering chemosensitivity. Am J Pathol (2007) 0.96
Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1. Haematologica (2009) 0.96
Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia. Blood (2007) 0.95
Increased c-Jun expression and reduced GATA2 expression promote aberrant monocytic differentiation induced by activating PTPN11 mutants. Mol Cell Biol (2009) 0.94
Chimaerism analyses and subsequent immunological intervention after stem cell transplantation in patients with juvenile myelomonocytic leukaemia. Br J Haematol (2005) 0.93
Clonal heterogeneity in childhood myelodysplastic syndromes--challenge for the detection of chromosomal imbalances by array-CGH. Genes Chromosomes Cancer (2010) 0.92
Uniparental disomy at chromosome 11p15.5 followed by HRAS mutations in embryonal rhabdomyosarcoma: lessons from Costello syndrome. Hum Mol Genet (2006) 0.92
Coping in long-term survivors of childhood cancer: relations to psychological distress. Psychooncology (2012) 0.91
Advances in the prognostication and management of advanced MDS in children. Br J Haematol (2011) 0.91
Comparison of the efficacy of rabbit and horse antithymocyte globulin for the treatment of severe aplastic anemia in children. Blood (2013) 0.91
Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7. Blood (2003) 0.91
Immunosuppressive therapy with anti-thymocyte globulin and cyclosporine A in selected children with hypoplastic refractory cytopenia. Haematologica (2007) 0.88
AKAP12, a gene with tumour suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignancies. Br J Haematol (2007) 0.87
Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood. Haematologica (2013) 0.87
Mutation analysis of CUTL1 in childhood myeloid neoplasias with monosomy 7. Leuk Res (2006) 0.86
Preclinical studies of treosulfan demonstrate potent activity in Ewing's sarcoma. Cancer Chemother Pharmacol (2007) 0.86
Haematopoietic stem cell survival and transplantation efficacy is limited by the BH3-only proteins Bim and Bmf. EMBO Mol Med (2012) 0.86
Molecular diagnosis of Shwachman-Diamond syndrome in a child with incomplete clinical disease phenotype. Pediatr Blood Cancer (2010) 0.85
Mesenteric chloroma with t(16;16) followed by acute myelomonocytic leukemia with clonal evolution. Cancer Genet Cytogenet (2007) 0.84
Constitutional trisomy 8p11.21-q11.21 mosaicism: a germline alteration predisposing to myeloid leukaemia. Br J Haematol (2011) 0.84
Deferasirox for managing iron overload in people with thalassaemia. Cochrane Database Syst Rev (2012) 0.84
Essential versus reactive thrombocythemia in children: retrospective analyses of 12 cases. Pediatr Blood Cancer (2007) 0.84
Exposure of anionic phospholipids serves as anti-inflammatory and immunosuppressive signal--implications for antiphospholipid syndrome and systemic lupus erythematosus. Immunobiology (2003) 0.83
X-linked sideroblastic anemia due to ALAS2 intron 1 enhancer element GATA-binding site mutations. Am J Hematol (2013) 0.83
How a rare pediatric neoplasia can give important insights into biological concepts: a perspective on juvenile myelomonocytic leukemia. Haematologica (2007) 0.82
Expression of the recombination-activating genes in extrafollicular lymphocytes but no apparent reinduction in germinal center reactions in human tonsils. Blood (2002) 0.82
Deferasirox for managing iron overload in people with myelodysplastic syndrome. Cochrane Database Syst Rev (2014) 0.81
JAK2 mutations other than V617F: a novel mutation and mini review. Leuk Res (2007) 0.81
HLA-identical umbilical cord blood transplantation from a sibling donor in juvenile myelomonocytic leukemia. Haematologica (2008) 0.81
Role of mutation independent constitutive activation of FLT3 in juvenile myelomonocytic leukemia. Haematologica (2007) 0.80
A semisynthetic bilaminar skin substitute used to treat pediatric full-body toxic epidermal necrolysis: wraparound technique in a 17-month-old girl. Arch Dermatol (2004) 0.80
Hematologic features and clinical course of an infant with Pearson syndrome caused by a novel deletion of mitochondrial DNA. J Pediatr Hematol Oncol (2003) 0.79
Differentiation of EBV-induced post-transplant Hodgkin lymphoma from Hodgkin-like post-transplant lymphoproliferative disease. Pediatr Transplant (2008) 0.79
Deferasirox for managing iron overload in people with myelodysplastic syndrome. Cochrane Database Syst Rev (2010) 0.79
High incidence of Fanconi anaemia in patients with a morphological picture consistent with refractory cytopenia of childhood. Br J Haematol (2012) 0.79
Juvenile myelomonocytic leukemia. Hematology (2005) 0.79
Expression analysis of alpha-NAC and ANX2 in juvenile myelomonocytic leukemia using SMART polymerase chain reaction and "virtual Northern" hybridization. Cancer Genet Cytogenet (2003) 0.78
Stem cell transplantation for paroxysmal nocturnal haemoglobinuria in childhood. Br J Haematol (2002) 0.78
Tracing the development of acute myeloid leukemia in CBL syndrome. Blood (2014) 0.78
Mutation analysis of the BRAF oncogene in juvenile myelomonocytic leukemia. Haematologica (2007) 0.77
Commitment of juvenile myelo-monocytic (JMML) leukemic cells to spontaneously differentiate into dendritic cells. Hematol J (2002) 0.76
Mutational analysis of SHOC2, a novel gene for Noonan-like syndrome, in JMML. Blood (2010) 0.76
Simultaneous control of third-degree graft-versus-host disease and prevention of recurrence of juvenile myelomonocytic leukemia (JMML) with 6-mercaptopurine following fulminant JMML relapse early after KIR-mismatched bone marrow transplantation. J Pediatr Hematol Oncol (2005) 0.76
Does SPRED1 contribute to leukemogenesis in juvenile myelomonocytic leukemia (JMML)? Blood (2010) 0.75
Mutations in the let-7 binding site - a mechanism of RAS activation in juvenile myelomonocytic leukemia? Haematologica (2010) 0.75
Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans. J Clin Invest (2017) 0.75
Mutations of the Shwachman-Bodian-Diamond syndrome gene in patients presenting with refractory cytopenia--do we have to screen? Haematologica (2009) 0.75
Sequential acquisition of IgH and TCR rearrangements during the preleukemic phase of acute lymphoblastic leukemia in an adolescent patient. Pediatr Blood Cancer (2011) 0.75
Abnormal promoter DNA methylation in juvenile myelomonocytic leukemia is not caused by mutation in DNMT3A. Blood (2011) 0.75
In vitro regulation of colony stimulating factor-mediated hematopoiesis in healthy individuals and patients with different types of myeloproliferative disease. Methods Mol Biol (2003) 0.75
The impact of medical education and networking on the outcome of leukemia treatment in developing countries. The experience of International Consortium on Acute Promyelocytic Leukemia (IC-APL). Hematology (2012) 0.75
Concomitant EBV-related B-cell proliferation and juvenile myelomonocytic leukemia in a 2-year-old child. Leuk Res (2007) 0.75
Mutation analysis of the HAX1 gene in childhood myelodysplastic syndrome. Br J Haematol (2009) 0.75
Myelodysplastic features in Griscelli syndrome. J Pediatr Hematol Oncol (2004) 0.75